Financial Counselors Inc Illumina, Inc. Transaction History

Financial Counselors Inc

$5.89 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$181.58 - $368.0 $110,037 - $223,008	-606 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$303.87 - $423.8 $6,685 - $9,323	22 Added 3.77%	606 $212,000
Q4 2021 Feb 10, 2022	SELL	$347.28 - $421.83 $29,866 - $36,277	-86 Reduced 12.84%	584 $222,000
Q3 2021 Oct 26, 2021	SELL	$405.61 - $524.84 $17,846 - $23,092	-44 Reduced 6.16%	670 $272,000
Q2 2021 Aug 03, 2021	BUY	$372.84 - $481.5 $28,708 - $37,075	77 Added 12.09%	714 $338,000

Q1 2021 Apr 29, 2021	SELL	$361.28 - $504.76 $50,217 - $70,161	-139 Reduced 17.91%	637 $245,000
Q4 2020 Feb 10, 2021	SELL	$292.7 - $370.96 $9,951 - $12,612	-34 Reduced 4.2%	776 $287,000
Q3 2020 Nov 16, 2020	SELL	$268.51 - $400.74 $58,803 - $87,762	-219 Reduced 21.28%	810 $250,000
Q2 2020 Aug 07, 2020	SELL	$256.46 - $373.01 $15,900 - $23,126	-62 Reduced 5.68%	1,029 $381,000
Q1 2020 Apr 23, 2020	BUY	$209.2 - $335.53 $61,923 - $99,316	296 Added 37.23%	1,091 $298,000
Q3 2019 Nov 08, 2019	BUY	$266.84 - $378.23 $212,137 - $300,692	795 New	795 $242,000
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $1.07 Million - $1.31 Million	-3,566 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$272.57 - $321.18 $37,069 - $43,680	136 Added 3.97%	3,566 $1.11 Million
Q4 2018 Feb 01, 2019	SELL	$272.46 - $366.54 $130,780 - $175,939	-480 Reduced 12.28%	3,430 $1.03 Million
Q3 2018 Oct 30, 2018	SELL	$279.04 - $367.06 $200,908 - $264,283	-720 Reduced 15.55%	3,910 $1.44 Million
Q2 2018 Aug 03, 2018	BUY	$228.17 - $292.07 $20,535 - $26,286	90 Added 1.98%	4,630 $1.29 Million
Q1 2018 Apr 26, 2018	BUY	$209.54 - $253.91 $951,311 - $1.15 Million	4,540 New	4,540 $1.07 Million

Others Institutions Holding ILMN

# of Institutions

875

Shares Held

139M

Call Options Held

1.09M

Put Options Held

1.91M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $16.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Counselors Inc with notifications on news.

Account